Does VANDETANIB Cause Malignant neoplasm progression? 47 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Malignant neoplasm progression have been filed in association with VANDETANIB (CAPRELSA). This represents 4.1% of all adverse event reports for VANDETANIB.
47
Reports of Malignant neoplasm progression with VANDETANIB
4.1%
of all VANDETANIB reports
5
Deaths
29
Hospitalizations
How Dangerous Is Malignant neoplasm progression From VANDETANIB?
Of the 47 reports, 5 (10.6%) resulted in death, 29 (61.7%) required hospitalization, and 1 (2.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VANDETANIB. However, 47 reports have been filed with the FAERS database.
What Other Side Effects Does VANDETANIB Cause?
Diarrhoea (216)
Fatigue (109)
Rash (101)
Electrocardiogram qt prolonged (89)
Hypertension (88)
Disease progression (62)
Acne (60)
Nausea (58)
Asthenia (52)
Headache (48)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which VANDETANIB Alternatives Have Lower Malignant neoplasm progression Risk?
VANDETANIB vs VARDENAFIL
VANDETANIB vs VARENICLINE
VANDETANIB vs VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
VANDETANIB vs VASOPRESSIN
VANDETANIB vs VECTIBIX